Covington Capital Management Amgen Inc Transaction History

Covington Capital Management

$23.2 Billion
Q3 2022

A detailed history of Covington Capital Management transactions in Amgen Inc stock. As of the latest transaction made, Covington Capital Management holds 54,600 shares of AMGN stock, worth $17.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

54,600

Previous 54,368 0.43%

Holding current value

$17.2 Million

Previous $13.2 Million 6.96%

% of portfolio

0.05%

Previous 0.54%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $52,074 - $58,730	232 Added 0.43%	54,600 $12.3 Million
Q2 2022 Jul 08, 2022	SELL	$230.71 - $256.74 $113,047 - $125,802	-490 Reduced 0.89%	54,368 $13.2 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $1.59 Million - $1.75 Million	7,234 Added 15.19%	54,858 $13.3 Million
Q4 2021 Feb 16, 2022	BUY	$198.88 - $227.6 $40,571 - $46,430	204 Added 0.43%	47,624 $10.7 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $109,955 - $128,826	-518 Reduced 1.08%	47,420 $10.1 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $69,373 - $76,964	297 Added 0.62%	47,938 $11.7 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $39,943 - $46,548	-180 Reduced 0.38%	47,641 $11.9 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $205,561 - $244,786	950 Added 2.03%	47,821 $11 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $235,823 - $262,254	1,005 Added 2.19%	46,871 $11.9 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $307,198 - $376,975	-1,553 Reduced 3.28%	45,866 $10.8 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $364 - $483	-2 Reduced -0.0%	47,419 $9.61 Million
Q4 2019 Feb 18, 2020	SELL	$189.21 - $243.2 $56,573 - $72,716	-299 Reduced 0.63%	47,421 $11.4 Million
Q3 2019 Nov 18, 2019	SELL	$174.11 - $208.62 $143,814 - $172,320	-826 Reduced 1.7%	47,720 $9.23 Million
Q2 2019 Aug 15, 2019	BUY	$166.7 - $195.41 $14,336 - $16,805	86 Added 0.18%	48,546 $8.95 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $99,478 - $112,134	550 Added 1.15%	48,460 $9.21 Million
Q4 2018 Feb 15, 2019	BUY	$178.4 - $208.25 $453,849 - $529,788	2,544 Added 5.61%	47,910 $9.33 Million
Q3 2018 Nov 15, 2018	SELL	$185.29 - $208.89 $53,363 - $60,160	-288 Reduced 0.63%	45,366 $9.4 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $32,711 - $36,742	197 Added 0.43%	45,654 $8.43 Million
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $433,910 - $507,078	2,561 Added 5.97%	45,457 $7.75 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $40,509 - $45,261	240 Added 0.56%	42,896 $7.46 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $44,499 - $50,806	266 Added 0.63%	42,656 $7.95 Million
Q2 2017 Aug 16, 2017	BUY	N/A	42,390	42,390 $7.3 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covington Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Covington Capital Management with notifications on news.

Account

Covington Capital Management Amgen Inc Transaction History